Clinical Trial Update: Fludarabine, Bendamustine, and Rituximab (FBR) for Relapsed Chronic Lymphocytic Leukemia (CLL) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating fludarabine, bendamustine, and rituximab (FBR) for relapsed chronic lymphocytic leukemia has completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Fludarabine, Bendamustine, and Rituximab (FBR)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-09-25